Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain, Pyrexia
Clinical narrative: I had fever; headache; body aches; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 29Mar2021 12:00 (Lot number: EP6955) at the age of 68 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Hypertension" (ongoing), notes: Concurrent: Hypertension; "Hypothyroidism" (ongoing), notes: Concurrent: Hypothyroidism; "Glaucoma" (ongoing), notes: Concurrent: Glaucoma; "Vitamin D3 insufficiency" (ongoing), notes: Concurrent: Vitamin D3 insufficiency; "depression" (ongoing), notes: Concurrent: Depression; "coronary calcification" (ongoing), notes: Concurrent: coronary calcification; "COVID-19", start date: 09Dec2020 (unspecified if ongoing), notes: History: COVID-19 on Approximately 09Dec2021; "frequent UTIs" (unspecified if ongoing), notes: History: frequent UTIs; "spinal fusion L4-L5" (unspecified if ongoing), notes: History: spinal fusion L4-L5; "osteoporosis" (unspecified if ongoing), notes: History: osteoporosis; "Known allergies: Penicillin" (unspecified if ongoing); "Known allergies: Sulfa" (unspecified if ongoing); "environmental allergies" (ongoing), notes: Concurrent: environmental allergies. Concomitant medication(s) included: ATORVASTATIN; METOPROLOL; BENAZEPRIL/HCTZ. Past drug history included: Erythromycin, reaction(s): "known allergies: Erythromycin"; Flagyl, reaction(s): "known allergies:Flagyl"; Ciprofloxacin, reaction(s): "known allergies:Ciprofloxacin". Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EN6206, Location of injection: Arm Left, Vaccine Administration Time: 12:00 PM), administration date: 05Mar2021, when the patient was 68 years old, for Covid-19 immunization. The following information was reported: PYREXIA (non-serious) with onset 30Mar2021, outcome "recovered" (Mar2021), described as "I had fever"; HEADACHE (non-serious) with onset 30Mar2021, outcome "recovered" (Mar2021), described as "headache"; PAIN (non-serious) with onset 30Mar2021, outcome "recovered" (Mar2021), described as "body aches". The patient received her booster on 18Oct2021. During the week of 08Nov2021 through 11Nov2021, the patient was caring for her sick granddaughter, and on 11Nov2021, the patient began had headaches, sinus congestion and fatigue. On 15Nov2021 and 16Nov2021, the patient additionally experienced low grade fever (99.8 degrees F). The fever resolved on 16Nov2021. On the date of this report, 18Nov2021, the headaches, sinus congestion, and fatigue were improving, but not totally resolved. The patient was seen at urgent care on 18Nov2021, had a rapid COVID-19 test, and tested positive for COVID- 19. The patient was also diagnosed with a secondary sinus infection for which the patient was prescribed doxycycline hyclate 100 mg capsules, twice daily for 10 days.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101722126 Same reporter/SD, Different dose (2nd)/AE